Pharmaceutical Resources Inc. said its Par Pharmaceutical unit entered a licensing agreement with Sano Corp., a maker of products using transdermal drug delivery systems.
Terms weren't disclosed.
The exclusive 10-year U.S. licensing agreement is for the distribution of generic pharmaceutical products using transdermal delivery.
Par Pharmaceutical, a maker of generic drugs, will provide funding assistance to Sano of Fort Lauderdale, Fla., for the development of products and will participate in the gross profits.
Pharmaceutical Resources said it has also subscribed for a "small equity position" in Sano, pending the completion of Sano's private placement.
